Egypt buys Russian medical devices for nitrogen oxide therapy

At the end of March 2024, RuSat RDS, a member of Rosatom, and the Egyptian holding Med Pharma Group signed a roadmap for cooperation in promoting the Tianox medical apparatus in the Egyptian market. The terms of the agreement provide for the purchase of Russian equipment, which, first, Egyptian doctors will use to treat newborns and older children with pulmonary arterial hypertension, and in the future - for the treatment and rehabilitation of adults with different diagnoses, including cardiovascular diseases.

Earlier, the parties have already agreed on scientific and technical cooperation and the use of nitrogen monoxide on the basis of the Tianox apparatus in Egyptian medical institutions. RuSat RDS specialists will provide support and advice on technical issues, as well as offer training programs and master classes for Egyptian medical workers.

source = Rosatom

The signing of this agreement was an important step to open up new prospects and expand the geography of the activities of RuSat RDS JSC, - comments Anatoly Myalitsin, director of specialized medical equipment at RuSat RDS JSC. - Therefore, now, within the framework of the road map implementation, our immediate plans include registration of the apparatus on the territory of the Republic as a medical device, as well as holding seminars aimed at exchange of experience between medical specialists of the Russian Federation and the Arab Republic of Egypt. We are confident that our cooperation with Egyptian partners will be successful and mutually beneficial for all parties.

"Tianox" is used for the therapy of nitrogen oxide in adults and children. The device has found application in such areas as pulmonology, cardiac surgery, transplantology, neonatology and rehabilitation.^[1]

Notes